Abstract
A double-blind cross-over trial of a micronized preparation of flumedroxone, an oral progestogen derivative, and a placebo was undertaken to determine whether this drug had prophylactic value in migraine. No benefit was found in males, or in females with no history of menstrual exacerbation of migraine. In women whose migraine was worse around the time of menstruation flumedroxone resulted in statistically fewer headaches of less severity.
With the dose used in this trial (micronized flumedroxone 10 mg. t.d.s.) side-effects were frequent, the commonest being polymenorrhagia, which occurred in half the women of reproductive age.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hudgson P., Foster J. B., Walton J. N. Methysergide and coronary artery disease. Am Heart J. 1967 Dec;74(6):854–855. doi: 10.1016/0002-8703(67)90105-6. [DOI] [PubMed] [Google Scholar]
- MEARS E., GRANT E. C. "Anovlar" as an oral contraceptive. Br Med J. 1962 Jul 14;2(5297):75–79. doi: 10.1136/bmj.2.5297.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SOUTHWELL N., WILLIAMS J. D., MACKENZIE I. METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE. Lancet. 1964 Mar 7;1(7332):523–524. doi: 10.1016/s0140-6736(64)92910-1. [DOI] [PubMed] [Google Scholar]
- Schwartz F. D., Kark R. M. Methysergide and retroperitoneal fibrosis. Am Heart J. 1966 Dec;72(6):843–844. doi: 10.1016/0002-8703(66)90172-4. [DOI] [PubMed] [Google Scholar]
- Shafey S., Scheinberg P. Vascular headaches and oral contraceptives. Ann Intern Med. 1966 Oct;65(4):863–863. doi: 10.7326/0003-4819-65-4-863_1. [DOI] [PubMed] [Google Scholar]
- Whewell J. Methysergide in prophylaxis of migraine: a clinical trial in general practice. Br Med J. 1966 Aug 13;2(5510):394–395. doi: 10.1136/bmj.2.5510.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whitty C. W., Hockaday J. M., Whitty M. M. The effect of oral contraceptives on migraine. Lancet. 1966 Apr 16;1(7442):856–859. doi: 10.1016/s0140-6736(66)90189-9. [DOI] [PubMed] [Google Scholar]